Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme

Jia-Bin Wang1, Feng-Hua Liu2, Jian-Hang Chen1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.

Abstract

Insights

This study identifies key molecular triplets (lncRNA-miRNA-mRNA interactions) that predict glioblastoma multiforme (GBM) patient survival. Knocking down a specific long noncoding RNA (TP73-AS1) reduced tumor cell growth and increased apoptosis.

Area of Science:

  • Molecular biology
  • Genomics
  • Cancer research

Background:

  • Long noncoding RNAs (lncRNAs) function as competing endogenous RNAs (ceRNAs), interacting with microRNAs (miRNAs) and messenger RNAs (mRNAs).
  • Dysregulated lncRNA-miRNA-mRNA interactions, termed triplets, are implicated in cancer development and progression.
  • The prognostic significance of these triplet biomarkers in glioblastoma multiforme (GBM) remains incompletely understood.

Purpose of the Study:

  • To construct a differential triplet interaction network (TriNet) comparing GBM and normal tissues.
  • To identify GBM survival-related triplets and investigate their functional roles.

Main Methods:

  • Integrated affinity propagation and hypergeometric methods to identify four significantly dysregulated modules.
  • Randomly split GBM samples into training and testing sets for validation.
  • Experimentally validated the role of TP73-AS1 and RFX1 in U87 GBM cells using siRNA, qRT-PCR, MTT, and AO/EB assays.

Main Results:

  • Four identified modules robustly distinguished between low- and high-survival GBM patients in both training and testing sets.
  • Core interactions within triplets were linked to tumor invasion, proliferation, and migration.
  • Knockdown of lncRNA TP73-AS1 reduced mRNA RFX1 expression and induced apoptosis in U87 cells.

Conclusions:

  • The identified triplet biomarkers offer insights into GBM patient prognosis.
  • Understanding these triplet interactions can advance therapeutic strategies for glioblastoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K